Robin goland
![robin goland robin goland](https://s.hdnux.com/photos/10/25/00/2183207/5/1200x0.jpg)
The scientists hope their approach could ultimately be used to develop insulin-producing cells that could help individuals with diabetes. As a result, the researchers were able to successfully entice these stem cells to grow into other types of cells, including nerve cartilage and muscle tissue. That is, when the egg developed into a tiny embryo - smaller than a pinhead and containing fewer than 100 cells - the stem cells contained therein had nearly the same genetic profile as the diabetes patient. To their surprise, this enabled the egg to be rebooted.
![robin goland robin goland](http://health.heraldtribune.com/files/2012/04/DIABETES_CHILDREN.jpg)
What the scientists at NYSCF and Columbia did differently was to leave the egg’s own nucleus intact. Other researchers had tried this basic approach before.
#ROBIN GOLAND SKIN#
They started by extracting nuclei from skin cells of people with type 1 diabetes and then injecting these nuclei into unfertilized human eggs. The scientists at NYSCF and Columbia put a new twist on an old cell-replacement strategy. But no method has ever proven safe and useful. Their breakthrough is considered significant because scientists have long sought to develop patient-specific embryonic stem cells as a way to grow replacement tissue for people with heart disease, Parkinson’s, and other illnesses. On October 5, researchers at the New York Stem Cell Foundation (NYSCF) and Columbia University Medical Center (CUMC) reported in the journal Nature that they have discovered a new way to create embryonic stem cells that contain a sick person’s unique DNA. It is the closest scientists have ever come to cloning human cells as a means of developing medical treatments. Dieter Egli, Mark Sauer, Robin Goland, and Rudolph Leibel.